Gut Microbiota as a Modulator of the Hypothalamic-Pituitary-Thyroid Axis

Abstract

Recent scientific evidence demonstrates that the gut microbiota significantly influences thyroid regulation through metabolic, immunological, and neuroendocrine mechanisms. Gut dysbiosis increases permeability, promotes low-grade systemic inflammation, and alters both the peripheral conversion of T4 to T3 and the central regulation of the hypothalamic-pituitary-thyroid axis. In autoimmune thyroid diseases, such as Graves' disease and Hashimoto's thyroiditis, characteristic patterns of reduced beneficial bacteria, decreased immunoregulatory metabolites, and activation of proinflammatory pathways are observed. Furthermore, chronic stress and activation of the HPA axis generate a feedback loop that exacerbates gut and thyroid dysfunction. Comprehensive therapeutic interventions aimed at modulating the microbiota—such as anti-inflammatory nutrition, probiotics, prebiotics, and targeted supplementation—show significant therapeutic potential for improving symptoms, clinical markers, and quality of life in patients with thyroid dysfunction.